[Thorofare, NJ] March 2026 – Healio Strategic Solutions (HSS), a Wyanoke Group company, is pleased to announce the appointment of David Mullin as Vice President of Healio AI Adoption + KOL Engagement.

In this new role, Mullin will lead physician and health care provider (HCP) adoption of Healio AI, working to integrate the platform into daily clinical workflows. He will serve as the main liaison between physician users and the Healio AI Build Team, ensuring real-world feedback directly informs product development and optimization.

Leveraging his longstanding KOL relationships in ophthalmology and dermatology, Mullin will drive adoption within those specialties while identifying and activating a cohort of physician beta testers, advisors, and ambassadors. As utilization expands, he will extend these efforts into additional priority specialties, including oncology, rheumatology, gastroenterology, primary care, and others.

“Healio has earned the trust of physicians over decades,” Mullin said. “Healio AI represents the next evolution of that relationship. I’m excited to work closely with our KOL partners to gather meaningful feedback, refine the platform, and ensure it delivers real value in everyday clinical practice. This is an opportunity to help shape how AI responsibly supports physicians and enhances patient care.”

Mullin has been with The Wyanoke Group for 26 years, spending much of his career in Healio News and most recently serving as Senior Director, Business Development & Market Strategy, Eye Care. His deep understanding of Healio’s physician audience and longstanding relationships across key specialty markets position him to accelerate adoption and engagement for Healio AI.

“David’s credibility with physicians and his deep knowledge of Healio’s ecosystem make him uniquely suited to lead this effort,” said Joan-Marie Stiglich, Chief AI Officer of Healio. “As we continue to advance Healio AI, his ability to bridge product development and clinical practice will be instrumental in driving meaningful adoption across specialties.”

For more information about Healio AI, visit HealioStrategicSolutions.com or contact David Mullin at [email protected].

###

About Healio Strategic Solutions
Healio Strategic Solutions (HSS) helps life sciences marketers reach healthcare professionals (HCPs) through our one-to-one relationship with the 3M+ HCPs on Healio’s platform. From educational activities to creative advertisements and advanced performance data, our clients’ content reaches broad and targeted audiences on the channels they use the most. For more information, visit HealioStrategicSolutions.com.

About Healio
Healio is a multichannel information platform, providing health care specialists with tailored news, information and education across 20+ specialties in support of their daily practice of medicine. Healio offers its core News, CME, Clinical Guidance and Community channels, plus the all-new Healio AI tool providing evidence-based intelligence at the point of care. For more information, visit Healio.com.